A
DGX icon

AlphaQuest’s Quest Diagnostics DGX Stock Holding History

AlphaQuest’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,173
Closed -$3.85M – 563
2025
Q4 		$3.85M Buy
22,173
+15,704
+243% +$2.86M 0.22% 54
2025
Q3 		$1.23M Buy
6,469
+6,284
+3,397% +$1.12M 0.08% 348
2025
Q2 		$33.2K Buy
185
+184
+18,400% +$32K ﹤0.01% 1712
2025
Q1 		$169 Hold
1
– – ﹤0.01% 1973
2024
Q4 		$151 Sell
1
-8,565
-100% -$1.33M ﹤0.01% 1619
2024
Q3 		$1.33M Sell
8,566
-9,521
-53% -$1.42M 0.12% 266
2024
Q2 		$2.48M Buy
18,087
+2,814
+18% +$385K 0.34% 39
2024
Q1 		$2.03M Buy
15,273
+12,036
+372% +$1.56M 0.35% 44
2023
Q4 		$446K Buy
+3,237
New +$426K 0.09% 387

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

AlphaQuest's DGX Position: Q1 2026 in Review

AlphaQuest sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 22,173 shares — an estimated $3.85M sold.

AlphaQuest first reported a position in DGX in Q4 2023 and held it in 9 quarters. The position peaked at $3.85M in Q4 2025. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • AlphaQuest reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 22,173 Quest Diagnostics shares in Q1 2026, an estimated $3.85M.
  • AlphaQuest first reported a position in Quest Diagnostics in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Quest Diagnostics position peaked at $3.85M in Q4 2025.
  • 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.